| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | NOVARTIS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$3,930,000 | |
| 2025 | NOVARTIS |
3rd Quarter (July 1 - Sep 30) AMENDED |
$1,700,000 | |
| 2025 | NOVARTIS |
2nd Quarter (Apr 1 - June 30) AMENDED |
$920,000 | |
| 2025 | NOVARTIS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$1,000,000 | |
| 2025 | NOVARTIS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$1,640,000 | |
| 2025 | NOVARTIS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$880,000 | |
| 2025 | NOVARTIS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$4,168,000 | |
| 2024 | NOVARTIS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$720,000 | |
| 2024 | NOVARTIS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$740,000 | |
| 2024 | NOVARTIS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$1,010,000 |
| Firm | Filings | Expenses |
|---|---|---|
| NOVARTIS | 85 | $126,100,226 |
| Issue | Activities |
|---|---|
| Trade (domestic/foreign) | 85 |
| Health Issues | 85 |
| Budget/Appropriations | 84 |
| Medicare/Medicaid | 84 |
| Copyright/Patent/Trademark | 74 |
| Taxation/Internal Revenue Code | 67 |
| Labor Issues/Antitrust/Workplace | 30 |
| Foreign Relations | 16 |
| Science/Technology | 13 |
| Veterans | 12 |
| Animals | 6 |
| Energy/Nuclear | 5 |
| Manufacturing | 2 |